Disc comfort: gene therapy for chronic back pain

Originally pablished by Megan Giboney, RegMedNet, on 17 May 2024

An extracellular vesicle-based gene therapy has repaired damaged intervertebral discs in a mouse model of chronic back pain.

Ohio State University (USA) researchers have developed a novel non-viral gene therapy to treat discogenic back pain, a type of chronic low back pain that results from the degeneration of intervertebral discs. Intervertebral discs function to separate the vertebrae, preventing them from grinding together, and provide a shock-absorbing effect and degeneration of these discs is responsible for approximately 40% of cases of discogenic back pain. Currently there are very few treatment options available and most rely on treating symptomatic pain rather than restoring the structure of the discs.

Original article

Comments

Popular posts from this blog

Research finds resin that destroys coronavirus on plastic surfaces

Engineered Rabies Virus Illuminates Neural Circuitry

Study discovers cellular activity that hints recycling is in our DNA